首页> 外国专利> Regulating Agents. inhibit or modulate connective tissue growth factor (ctgf) activity and / or expression as a sole means of decreasing intraocular pressure and treating glaucomatous retinopathies / optic neuropathies

Regulating Agents. inhibit or modulate connective tissue growth factor (ctgf) activity and / or expression as a sole means of decreasing intraocular pressure and treating glaucomatous retinopathies / optic neuropathies

机译:调节剂。抑制或调节结缔组织生长因子(ctgf)的活性和/或表达,作为降低眼内压和治疗青光眼性视网膜病变/视神经病变的唯一手段

摘要

"AGENTS REGULATING, INHIBITING OR MODULATING THE ACTIVITY AND / OR EXPRESSION OF THE CONJUNCTIVE TISSUE GROWTH FACTOR (CTGF) AS A SINGLE MEASURE TO REDUCE INTRAOCULAR PRESSURE AND TREAT GLAUCOMATOUS / NEUROPATHY RETINOPATHIES. The present invention relates to a process for decreasing intraocular pressure and providing neuroprotection to a patient in need thereof by administering a therapeutically effective amount of at least one non-nucleotide or non-protein agent. which inhibits the expression and / or signaling of connective tissue growth factor (CTGF).
机译:“调节,抑制或调节结缔组织生长因子(CTGF)的活性和/或表达的药物作为减轻眼内压和治疗胶质细胞/神经病性视网膜病变的单一措施。本发明涉及降低压力的方法通过施用治疗有效量的至少一种抑制结缔组织生长因子(CTGF)的表达和/或信号传导的非核苷酸或非蛋白质剂,对需要其的患者进行神经保护。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号